Clinical Review

Hepatocellular Carcinoma: To Biopsy or Not?

Case in Point

Author and Disclosure Information

Hepatocellular carcinoma (HCC) accounts for 90% of all primary liver cancers and is the third leading cause of cancer-related mortality. Although HCC is often deadly, it is potentially curable if diagnosed at an early stage. Generally, needle biopsy of a suspicious liver lesion is not recommended because it raises the risk of needle track seeding.


 

Recommended Reading

Assessing Health-Related Quality of Life in Veterans With Nonmuscle-Invasive Bladder Cancer
AVAHO
Radical Radiotherapy in the Elderly
AVAHO
Cancer Treatment-Related Urogenital Disorders Underestimated
AVAHO
Commission on Cancer Accreditation of all VA Medical Centers—A Goal Within Reach
AVAHO
Errors in Opioid Prescribing
AVAHO
Racial Differences in Androgen-Deprivation Therapy
AVAHO
More Reliable and Safer Prevention of Vitamin D Deficiency
AVAHO
Easing a Common Problem in Cancer Patients
AVAHO
Reassessing Risk Factors for Ovarian Cancer
AVAHO
Korean Veterans Affected by New Benefits Policy
AVAHO